Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Usana Health Sciences
USNA
Market cap
$385M
Overview
Fund Trends
Analyst Outlook
Journalist POV
21.07
USD
+0.56
2.73%
At close
Updated
Oct 16, 4:00 PM EDT
Pre-market
After hours
21.07
0.00
0%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
2.73%
5 days
-6.4%
1 month
-31.08%
3 months
-32.75%
6 months
-10.07%
Year to date
-42.1%
1 year
-42.57%
5 years
-72.68%
10 years
-66.44%
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
50%
Negative
Positive
Neutral
Negative
Neutral
PRNewsWire
11 hours ago
USANA's Vitamin D Supplement Shines Bright with ConsumerLab.com Seal of Approval--Setting the Standard for Product Quality
SALT LAKE CITY , Oct. 16, 2025 /PRNewswire/ -- USANA (NYSE:USNA), a global leader in cellular nutrition, is bringing a little more sunshine to wellness. Its top-rated Vitamin D supplement has officially earned the prestigious ConsumerLab.com Seal of Approval—a recognition reserved for products that deliver on purity, potency, and scientific precision.
Neutral
Seeking Alpha
3 days ago
USANA Q3 2025 Preview: Short-Term Challenges Amid Strategic Transition
USANA Health Sciences faces short-term pain as Q3 preliminary results reveal declining profitability despite modest sales growth and ongoing business transition. USNA's new Brand Partner compensation plan and Hiya acquisition are causing temporary disruptions, but management expects double-digit Hiya growth and operational improvements by 2026. Valuation remains attractive, with USNA trading at significant discounts to sector averages, supported by a strong balance sheet and no debt.
Neutral
Business Wire
7 days ago
USANA Health Sciences Provides Preliminary Third Quarter Results
SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the third quarter ended September 27, 2025. The Company anticipates third quarter 2025 net sales will be approximately $214 million, which compares with $200 million in the prior-year period. Earnings from operations are expected to be $1.2 million for the current-year quarter, or 0.6% of net sales, as compared to $15.6 million in the third quarter of 2024. “Third quarter operating.
Neutral
PRNewsWire
10 days ago
Award-Winning Leadership: USANA's Chief Scientific Officer Honored with Women Tech Award
Dr. Kathryn Armstrong named a "Leadership Excellence Award" winner SALT LAKE CITY , Oct. 6, 2025 /PRNewswire/ -- USANA (NYSE:USNA) is proud to announce that its chief scientific officer, Dr. Kathryn Armstrong, has received the Women Tech Award from the Women Tech Council of Utah. The Women Tech Award is a distinguished recognition platform that celebrates women who are significantly contributing to the expansion and innovation within the technology sector.
Neutral
PRNewsWire
15 days ago
USANA Chairman Kevin Guest Shares 6 Ways Giving Back Strengthens Leaders
SALT LAKE CITY , Oct. 1, 2025 /PRNewswire/ -- As Emotional Wellness Month begins, Kevin Guest, executive chairman at USANA Health Sciences (NYSE: USNA), is spotlighting service as one of the most overlooked but powerful ways to strengthen mental well-being and emotional balance, especially for those in leadership roles. "Service is the clearest expression of our best selves," said Guest, bestselling author of All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony.
Positive
Zacks Investment Research
1 month ago
USNA vs. STVN: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks is more attractive to value investors?
Positive
Zacks Investment Research
1 month ago
Is USANA Health Sciences (USNA) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Neutral
PRNewsWire
1 month ago
USANA Launches Next-Generation Celavive Skincare: Advanced Formulas, Expert Ambassadors, Proven Results
Breakthrough products and upgrades redefine cellular skincare for radiant, resilient skin SALT LAKE CITY , Sept. 11, 2025 /PRNewswire/ -- USANA (NYSE: USNA), a global leader in cellular nutrition, has unveiled the next evolution of its Celavive skincare brand.
Positive
Zacks Investment Research
1 month ago
5 Undervalued Stocks That Are Worth Buying in September
StoneCo, USANA Health Sciences, KT, PagSeguro Digital and Itron stand out as undervalued picks with solid growth prospects this September.
Neutral
PRNewsWire
1 month ago
USANA Expands Its Nutritionals Line With Powerful New Products and Enhanced Formulas
Innovative offerings designed to help people live more vibrant lives SALT LAKE CITY , Sept. 9, 2025 /PRNewswire/ -- USANA, a worldwide leader in the field of cellular nutrition, has announced a fresh set of advancements to its existing Nutritionals product line.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close